Secondary hyperparathyroidism

Oct 29, 2019

Fujirebio Diagnostics Announces FDA Clearance of Lumipulse G whole PTH Assay

Oct 29, 2018

Rockwell Medical Schedules Third Quarter 2018 Conference Call

Aug 03, 2018

Rockwell Medical Schedules Second Quarter 2018 Business Update Conference Call and Provides Timeline of Form 10-Q Filing

Jul 30, 2018

Rockwell Medical Announces Engagement of Marcum LLP as New Independent Auditor

Jul 16, 2018

Calcitriol New Contract Manufacturing Submission Receives FDA Approval and Allows Rockwell Medical Commercialization of Calcitriol

Aug 31, 2017

European Commission Approves Expanded Use Of Mimpara® (Cinacalcet) For The Treatment Of Secondary Hyperparathyroidism In Children With End-Stage Renal Disease On Dialysis

Aug 10, 2017

Changes Afoot in the Management of CKD Mineral Bone Disorder Reinforced by a Clinical Practice Guideline Update from KDIGO

Jun 23, 2017

Amgen Receives Positive CHMP Opinion To Expand Use Of Mimpara® (cinacalcet) For The Treatment Of Secondary Hyperparathyroidism In Certain Children With End-Stage Renal Disease On Dialysis